EMBECTA CORP (EMBC) Fundamental Analysis & Valuation

NASDAQ:EMBC • US29082K1051

9.07 USD
-0.37 (-3.92%)
At close: Mar 6, 2026
9.01 USD
-0.06 (-0.66%)
Pre-Market: 3/9/2026, 4:00:00 AM

This EMBC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

EMBC gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 184 industry peers in the Health Care Equipment & Supplies industry. While EMBC has a great profitability rating, there are some minor concerns on its financial health. EMBC may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

7

1. EMBC Profitability Analysis

1.1 Basic Checks

  • In the past year EMBC was profitable.
  • EMBC had a positive operating cash flow in the past year.
  • In the past 5 years EMBC has always been profitable.
  • Each year in the past 5 years EMBC had a positive operating cash flow.
EMBC Yearly Net Income VS EBIT VS OCF VS FCFEMBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • EMBC's Return On Assets of 13.11% is amongst the best of the industry. EMBC outperforms 93.48% of its industry peers.
  • With an excellent Return On Invested Capital value of 27.76%, EMBC belongs to the best of the industry, outperforming 98.91% of the companies in the same industry.
  • EMBC had an Average Return On Invested Capital over the past 3 years of 22.63%. This is significantly above the industry average of 9.15%.
  • The 3 year average ROIC (22.63%) for EMBC is below the current ROIC(27.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.11%
ROE N/A
ROIC 27.76%
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
EMBC Yearly ROA, ROE, ROICEMBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

1.3 Margins

  • EMBC's Profit Margin of 12.92% is amongst the best of the industry. EMBC outperforms 86.96% of its industry peers.
  • In the last couple of years the Profit Margin of EMBC has declined.
  • EMBC's Operating Margin of 30.45% is amongst the best of the industry. EMBC outperforms 97.28% of its industry peers.
  • In the last couple of years the Operating Margin of EMBC has declined.
  • EMBC has a better Gross Margin (63.17%) than 67.39% of its industry peers.
  • EMBC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 30.45%
PM (TTM) 12.92%
GM 63.18%
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
EMBC Yearly Profit, Operating, Gross MarginsEMBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. EMBC Health Analysis

2.1 Basic Checks

  • EMBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, EMBC has more shares outstanding
  • Compared to 5 years ago, EMBC has more shares outstanding
  • EMBC has a worse debt/assets ratio than last year.
EMBC Yearly Shares OutstandingEMBC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
EMBC Yearly Total Debt VS Total AssetsEMBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 2.12 indicates that EMBC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of EMBC (2.12) is better than 62.50% of its industry peers.
  • EMBC has a debt to FCF ratio of 6.77. This is a slightly negative value and a sign of low solvency as EMBC would need 6.77 years to pay back of all of its debts.
  • EMBC has a better Debt to FCF ratio (6.77) than 74.46% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.77
Altman-Z 2.12
ROIC/WACC3.63
WACC7.65%
EMBC Yearly LT Debt VS Equity VS FCFEMBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B

2.3 Liquidity

  • EMBC has a Current Ratio of 2.64. This indicates that EMBC is financially healthy and has no problem in meeting its short term obligations.
  • EMBC has a Current ratio of 2.64. This is comparable to the rest of the industry: EMBC outperforms 53.26% of its industry peers.
  • EMBC has a Quick Ratio of 1.87. This is a normal value and indicates that EMBC is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of EMBC (1.87) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 1.87
EMBC Yearly Current Assets VS Current LiabilitesEMBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. EMBC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.72% over the past year.
  • Measured over the past years, EMBC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -26.21% on average per year.
  • The Revenue has decreased by -2.53% in the past year.
  • Measured over the past years, EMBC shows a decrease in Revenue. The Revenue has been decreasing by -0.10% on average per year.
EPS 1Y (TTM)20.72%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%9.23%
Revenue 1Y (TTM)-2.53%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-0.27%

3.2 Future

  • EMBC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.78% yearly.
  • The Revenue is expected to grow by 1.59% on average over the next years.
EPS Next Y-3.32%
EPS Next 2Y-0.55%
EPS Next 3Y0.78%
EPS Next 5YN/A
Revenue Next Year-1%
Revenue Next 2Y-0.54%
Revenue Next 3Y-0.15%
Revenue Next 5Y1.59%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EMBC Yearly Revenue VS EstimatesEMBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EMBC Yearly EPS VS EstimatesEMBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

8

4. EMBC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 2.99 indicates a rather cheap valuation of EMBC.
  • EMBC's Price/Earnings ratio is rather cheap when compared to the industry. EMBC is cheaper than 99.46% of the companies in the same industry.
  • EMBC is valuated cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
  • EMBC is valuated cheaply with a Price/Forward Earnings ratio of 3.09.
  • EMBC's Price/Forward Earnings ratio is rather cheap when compared to the industry. EMBC is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of EMBC to the average of the S&P500 Index (24.60), we can say EMBC is valued rather cheaply.
Industry RankSector Rank
PE 2.99
Fwd PE 3.09
EMBC Price Earnings VS Forward Price EarningsEMBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EMBC indicates a rather cheap valuation: EMBC is cheaper than 98.91% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, EMBC is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.61
EV/EBITDA 4.67
EMBC Per share dataEMBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

  • The decent profitability rating of EMBC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.55%
EPS Next 3Y0.78%

6

5. EMBC Dividend Analysis

5.1 Amount

  • EMBC has a Yearly Dividend Yield of 6.36%, which is a nice return.
  • The stock price of EMBC dropped by -22.41% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • EMBC's Dividend Yield is rather good when compared to the industry average which is at 0.21. EMBC pays more dividend than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, EMBC pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.36%

5.2 History

  • EMBC has been paying a dividend for over 5 years, so it has already some track record.
  • EMBC has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EMBC Yearly Dividends per shareEMBC Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

  • 25.16% of the earnings are spent on dividend by EMBC. This is a low number and sustainable payout ratio.
DP25.16%
EPS Next 2Y-0.55%
EPS Next 3Y0.78%
EMBC Yearly Income VS Free CF VS DividendEMBC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
EMBC Dividend Payout.EMBC Dividend Payout, showing the Payout Ratio.EMBC Dividend Payout.PayoutRetained Earnings

EMBC Fundamentals: All Metrics, Ratios and Statistics

EMBECTA CORP

NASDAQ:EMBC (3/6/2026, 8:14:04 PM)

Premarket: 9.01 -0.06 (-0.66%)

9.07

-0.37 (-3.92%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-05
Earnings (Next)05-07
Inst Owners101.67%
Inst Owner Change2.69%
Ins Owners1.52%
Ins Owner Change33.15%
Market Cap537.13M
Revenue(TTM)1.08B
Net Income(TTM)139.50M
Analysts51.11
Price Target17 (87.43%)
Short Float %6.91%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield 6.36%
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP25.16%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.38%
Min EPS beat(2)-8.66%
Max EPS beat(2)3.89%
EPS beat(4)3
Avg EPS beat(4)16.72%
Min EPS beat(4)-8.66%
Max EPS beat(4)41.68%
EPS beat(8)7
Avg EPS beat(8)31.67%
EPS beat(12)9
Avg EPS beat(12)19.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.67%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.76%
Revenue beat(4)1
Avg Revenue beat(4)0.19%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)4.13%
Revenue beat(8)4
Avg Revenue beat(8)1.14%
Revenue beat(12)8
Avg Revenue beat(12)1.57%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-36.74%
EPS NQ rev (3m)-36.74%
EPS NY rev (1m)-3.26%
EPS NY rev (3m)-3.26%
Revenue NQ rev (1m)-9.83%
Revenue NQ rev (3m)-10.85%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-1%
Valuation
Industry RankSector Rank
PE 2.99
Fwd PE 3.09
P/S 0.5
P/FCF 2.61
P/OCF 2.51
P/B N/A
P/tB N/A
EV/EBITDA 4.67
EPS(TTM)3.03
EY33.41%
EPS(NY)2.94
Fwd EY32.39%
FCF(TTM)3.48
FCFY38.32%
OCF(TTM)3.62
OCFY39.88%
SpS18.23
BVpS-10.35
TBVpS-10.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 13.11%
ROE N/A
ROCE 39.66%
ROIC 27.76%
ROICexc 36.66%
ROICexgc 38%
OM 30.45%
PM (TTM) 12.92%
GM 63.18%
FCFM 19.06%
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
ROICexc(3y)32.83%
ROICexc(5y)43.39%
ROICexgc(3y)34.19%
ROICexgc(5y)45.56%
ROCE(3y)32.33%
ROCE(5y)45.63%
ROICexgc growth 3Y-16%
ROICexgc growth 5Y-7.86%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y-7.62%
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
F-Score7
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.77
Debt/EBITDA 3.73
Cap/Depr 20.19%
Cap/Sales 0.78%
Interest Coverage 250
Cash Conversion 57.83%
Profit Quality 147.53%
Current Ratio 2.64
Quick Ratio 1.87
Altman-Z 2.12
F-Score7
WACC7.65%
ROIC/WACC3.63
Cap/Depr(3y)49.26%
Cap/Depr(5y)65.23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)2.02%
Profit Quality(3y)91.71%
Profit Quality(5y)109.85%
High Growth Momentum
Growth
EPS 1Y (TTM)20.72%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%9.23%
EPS Next Y-3.32%
EPS Next 2Y-0.55%
EPS Next 3Y0.78%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.53%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-0.27%
Revenue Next Year-1%
Revenue Next 2Y-0.54%
Revenue Next 3Y-0.15%
Revenue Next 5Y1.59%
EBIT growth 1Y30.01%
EBIT growth 3Y-7.11%
EBIT growth 5Y-7.53%
EBIT Next Year15.84%
EBIT Next 3Y5.44%
EBIT Next 5YN/A
FCF growth 1Y779.21%
FCF growth 3Y-22.26%
FCF growth 5Y-16.78%
OCF growth 1Y3793.1%
OCF growth 3Y-22.52%
OCF growth 5Y-17.41%

EMBECTA CORP / EMBC FAQ

What is the fundamental rating for EMBC stock?

ChartMill assigns a fundamental rating of 6 / 10 to EMBC.


What is the valuation status for EMBC stock?

ChartMill assigns a valuation rating of 8 / 10 to EMBECTA CORP (EMBC). This can be considered as Undervalued.


Can you provide the profitability details for EMBECTA CORP?

EMBECTA CORP (EMBC) has a profitability rating of 7 / 10.


What are the PE and PB ratios of EMBECTA CORP (EMBC) stock?

The Price/Earnings (PE) ratio for EMBECTA CORP (EMBC) is 2.99 and the Price/Book (PB) ratio is -0.88.


Can you provide the expected EPS growth for EMBC stock?

The Earnings per Share (EPS) of EMBECTA CORP (EMBC) is expected to decline by -3.32% in the next year.